Found 123 matching trials
Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors
NAThis study is a Compassionate clinical study for the treatment of Malignant...
Location
Hadassah Ein Kerem
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
PHASE2This phase II trial examines the use of blood-based biomarkers is to help i...
Location
Mayo Clinic in Arizona
Decision Aid for Renal Therapy
NAGood communication among patients, their families and loved ones, and their...
Location
University of California San Diego
Effects of Simulated Equestrian Therapy on Motor Proficiency and Gait Parameters Among Down Syndrome Children
NAAccording to the World Health Organization (WHO) and United Nations Childre...
Location
Ziauddin University and Dar-ul-Sukoon
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
PHASE2This phase II trial tests how well giving dasatinib and quercetin with cycl...
Location
Mayo Clinic in Rochester
Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer
NAA unique approach for cancer treatment employing intratumoral diffusing alp...
Location
RAMBAM Health Care Campus
Comparison Of VR & CPT, With And Without Lifestyle Modification, On ULD In Breast Cancer Survivors
NAThe proposed study will compare the effect of an application of non-immersi...
Status
Active Not Recruiting
Location
District Head Quarters Hospital
Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma
NAA unique approach for cancer treatment employing intratumoral diffusing alp...
Location
Davidof Cancer Institution at the Rabin Medical Center Israel
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
NAThis is a multi-center clinical study enrolling up to 50 participants. The ...
Location
Banner MD Anderson Cancer Center
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
PHASE1Study CP-MGC018-02 is a study of vobramitamab duocarmazine (MGC018) in comb...
Location
University of California, Los Angeles